TrialMenopause (New York, N.Y.)2019

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.

James A Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.